Scleroderma en coup de sabre with central nervous system and ophthalmologic involvement: Treatment of ocular symptoms with interferon gamma

Journal of the American Academy of Dermatology

Volumn 49, Issue 3, 2003, Pages 543-546

  Obermoser, Gerlinde ^b   Pfausler, Bettina E ^b   Linder, Dennis M ^b   Sepp, Norbert T ^a  

^a Universitatsklinik fuer Dermatologie und Venerologie Innsbruck   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; AZATHIOPRINE; CARBAMAZEPINE; CONTRAST MEDIUM; CORTICOSTEROID; CYCLOSPORIN; GADOLINIUM; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PARACETAMOL; PENICILLAMINE; PENICILLIN DERIVATIVE; PHENYTOIN; PSORALEN; RECOMBINANT GAMMA INTERFERON; RETINOID; VITAMIN D;

ADULT; ARTICLE; BRAIN BIOPSY; CASE REPORT; CONTRAST ENHANCEMENT; DISEASE DURATION; EYE DISEASE; EYE PAIN; FEMALE; FLU LIKE SYNDROME; GLIOSIS; HUMAN; IMMUNOTHERAPY; INFLAMMATORY INFILTRATE; LINEAR SCLERODERMA; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SCLERODERMA; SEIZURE; SKIN DISEASE; SKIN MANIFESTATION; TREATMENT OUTCOME; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

EID: 0041825313     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0190-9622(03)00901-0     Document Type: Article

References (17)

1. Itin PH, Schiller P. Double-lined frontoparietal scleroderma en coup de sabre. Dermatology 1999;199:185-6.
2. Ramboer K, Demaerel PH, Baert AL, Casteels I, Dralands G. Linear scleroderma with orbital involvement: follow up and magnetic resonance imaging. Br J Ophthalmol 1997;81:90-1.
3. Chung MH, Sum J, Morrell MJ, Horoupian DS. Intracerebral involvement in scleroderma en coup de sabre: report of a case with neuropathologic findings. Ann Neurol 1995;37:679-81.
4. Orozco-Covarrubias L, Guzman-Meza A, Ridaura-Sanz C, Carrasco Daza D, Sosa-de-Martinez C, Ruiz-Maldonado R. Scleroderma 'en coup de sabre' and progressive facial hemiatrophy. Is it possible to differentiate them? J Eur Acad Dermatol Venereol 2002;16:361-6.
5. van Bergen BH, van Dooren-Greebe RJ, Fiselier TJ, Koopman RJ. D-Penizillamin in der Behandlung von Sklerodermie "en coup de sabre." Hautarzt 1997;48:42-4.
6. Cunningham BB, Landells ID, Langman C, Sailer DE, Paller AS. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol 1998;39:211-5.
7. Hulshof MM, Bouwes Bavinck JN, Bergman W, Masclee AA, Heickendorff L, Breedveld FC, et al. Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol 2000;43: 1017-23.
8. 3 (calcitriol) in seven children. Pediatr Dermatol 1999;16:53-8.
9. Higashi Y, Kanekura T, Fukumaru K, Kanzaki T. Scleroderma en coup de sabre with central nervous system involvement. J Dermatol 2001;27:486-8.
10. Neldner KH. Treatment of localized linear scleroderma with phenytoin. Cutis 1978;22:569-72.
11. Granstein RD, Flotte TJ, Amento EP. Interferons and collagen production. J Invest Dermatol 1990;95(Suppl):75-80S.
12. Black CM, Silman AJ, Herrick AI, Denton CP, Wilson H, Newman J, et al. Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1999;42:299-305.
13. Hunzelmann N, Anders S, Fierlbeck G, Hein R, Herrmann K, Albrecht M, et al. Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma. J Am Acad Dermatol 1997;36:433-5.
14. Grassegger A, Schuler G, Hessenberger G, Walder-Hantich B, Jabkowski J, MacHeiner W, et al. Interferon-gamma in the treatment of systemic sclerosis: a randomised controlled multicentre trial. Br J Dermatol 1998;139:639-48.
15. Stone J, Franks AJ, Guthrie JA, Johnson MH. Scleroderma "en coup de sabre:" pathological evidence of intracerebral inflammation. J Neurol Neurosurg Psychiatry 2001;70:382-5.
16. Dubeau F, Andermann F, Robitaille Y, Olivier A, Wilkinson R, Delgado-Escueta A. Morphea or focal scleroderma of the brain: intractable epilepsy and clinicopathologic correlation. Epilepsia 1988;29:712-3.
17. Rosenwasser TA, Eisen AT. Scleroderma. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in general medicine. 4th ed. New York: McGraw-Hill; 1993. p. 2156-67.